FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2153763521> ?p ?o ?g. }

• W2153763521 endingPage "E1861" @default.
• W2153763521 startingPage "E1854" @default.
• W2153763521 abstract "The chronic kidney disease (CKD)-mineral and bone disorder (MBD) syndrome is an important contributor to the CKD-associated cardiovascular disease and high mortality rates. Sclerostin, a protein synthesized in osteocytes, is a potent downregulator of bone metabolism and a novel candidate for the bone-vascular axis in CKD patients. We tested whether serum sclerostin values are predictive for all-cause mortality and cardiovascular events (CVEs) in a CKD population. Serum sclerostin was obtained from 173 CKD (stage 3–5) and 47 control patients, and its concentration was correlated with estimated glomerular filtration rate and to mineral and vascular abnormalities that are present in the CKD evolution. All-cause mortality and CVEs were also analyzed in relation to serum sclerostin values. Patients with CKD showed higher sclerostin levels (median 63.5 pmol/L vs 52 pmol/L, P < .001) than controls, with values progressively higher across the CKD stages. In univariate analysis, serum sclerostin concentrations were correlated with gender, estimated glomerular filtration rate, flow-mediated dilatation, and endothelium-independent vasodilatation as markers of endothelial dysfunction and with different serum CKD-MBD–associated parameters. However, in multivariate analysis, only gender, fibroblast growth factor-23, phosphate, flow-mediated dilatation, and cholesterol remained significantly associated with sclerostin levels. During the observational period, there were 19 deaths and 50 CVEs. In survival analysis, different sclerostin levels were associated with all-cause mortality and CVEs in these patients. This is the first study that shows that serum sclerostin values are associated, even after multiple adjustments, with fatal and nonfatal CVEs in a nondialyzed CKD population." @default.
• W2153763521 created "2016-06-24" @default.
• W2153763521 creator A5009327224 @default.
• W2153763521 creator A5010062770 @default.
• W2153763521 creator A5010366572 @default.
• W2153763521 creator A5021426220 @default.
• W2153763521 creator A5022715104 @default.
• W2153763521 creator A5029946748 @default.
• W2153763521 creator A5036131841 @default.
• W2153763521 creator A5037137608 @default.
• W2153763521 creator A5039946250 @default.
• W2153763521 creator A5046561566 @default.
• W2153763521 creator A5049079690 @default.
• W2153763521 creator A5049717566 @default.
• W2153763521 creator A5057484947 @default.
• W2153763521 creator A5078784051 @default.
• W2153763521 creator A5087360999 @default.
• W2153763521 creator A5090468041 @default.
• W2153763521 date "2014-10-01" @default.
• W2153763521 modified "2023-10-16" @default.
• W2153763521 title "Serum Sclerostin and Adverse Outcomes in Nondialyzed Chronic Kidney Disease Patients" @default.
• W2153763521 cites W1555489744 @default.
• W2153763521 cites W1561791332 @default.
• W2153763521 cites W1581795935 @default.
• W2153763521 cites W1759911964 @default.
• W2153763521 cites W1965141016 @default.
• W2153763521 cites W1974413125 @default.
• W2153763521 cites W1981582225 @default.
• W2153763521 cites W1982990064 @default.
• W2153763521 cites W1987586045 @default.
• W2153763521 cites W1989288117 @default.
• W2153763521 cites W1992893431 @default.
• W2153763521 cites W2001430062 @default.
• W2153763521 cites W2001597454 @default.
• W2153763521 cites W2004352630 @default.
• W2153763521 cites W2013595591 @default.
• W2153763521 cites W2031567798 @default.
• W2153763521 cites W2032471431 @default.
• W2153763521 cites W2047856826 @default.
• W2153763521 cites W2049986143 @default.
• W2153763521 cites W2055864845 @default.
• W2153763521 cites W2060241006 @default.
• W2153763521 cites W2063506869 @default.
• W2153763521 cites W2071432242 @default.
• W2153763521 cites W2072087746 @default.
• W2153763521 cites W2084730438 @default.
• W2153763521 cites W2097969657 @default.
• W2153763521 cites W2103135572 @default.
• W2153763521 cites W2122851658 @default.
• W2153763521 cites W2123390113 @default.
• W2153763521 cites W2123937422 @default.
• W2153763521 cites W2129544443 @default.
• W2153763521 cites W2137100897 @default.
• W2153763521 cites W2138512695 @default.
• W2153763521 cites W2145632027 @default.
• W2153763521 cites W2149030597 @default.
• W2153763521 cites W2160234571 @default.
• W2153763521 cites W2164137478 @default.
• W2153763521 cites W2169848124 @default.
• W2153763521 cites W2172159264 @default.
• W2153763521 cites W2487377689 @default.
• W2153763521 doi "https://doi.org/10.1210/jc.2014-2042" @default.
• W2153763521 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25057883" @default.
• W2153763521 hasPublicationYear "2014" @default.
• W2153763521 type Work @default.
• W2153763521 sameAs 2153763521 @default.
• W2153763521 citedByCount "94" @default.
• W2153763521 countsByYear W21537635212014 @default.
• W2153763521 countsByYear W21537635212015 @default.
• W2153763521 countsByYear W21537635212016 @default.
• W2153763521 countsByYear W21537635212017 @default.
• W2153763521 countsByYear W21537635212018 @default.
• W2153763521 countsByYear W21537635212019 @default.
• W2153763521 countsByYear W21537635212020 @default.
• W2153763521 countsByYear W21537635212021 @default.
• W2153763521 countsByYear W21537635212022 @default.
• W2153763521 countsByYear W21537635212023 @default.
• W2153763521 crossrefType "journal-article" @default.
• W2153763521 hasAuthorship W2153763521A5009327224 @default.
• W2153763521 hasAuthorship W2153763521A5010062770 @default.
• W2153763521 hasAuthorship W2153763521A5010366572 @default.
• W2153763521 hasAuthorship W2153763521A5021426220 @default.
• W2153763521 hasAuthorship W2153763521A5022715104 @default.
• W2153763521 hasAuthorship W2153763521A5029946748 @default.
• W2153763521 hasAuthorship W2153763521A5036131841 @default.
• W2153763521 hasAuthorship W2153763521A5037137608 @default.
• W2153763521 hasAuthorship W2153763521A5039946250 @default.
• W2153763521 hasAuthorship W2153763521A5046561566 @default.
• W2153763521 hasAuthorship W2153763521A5049079690 @default.
• W2153763521 hasAuthorship W2153763521A5049717566 @default.
• W2153763521 hasAuthorship W2153763521A5057484947 @default.
• W2153763521 hasAuthorship W2153763521A5078784051 @default.
• W2153763521 hasAuthorship W2153763521A5087360999 @default.
• W2153763521 hasAuthorship W2153763521A5090468041 @default.
• W2153763521 hasBestOaLocation W21537635211 @default.
• W2153763521 hasConcept C104317684 @default.
• W2153763521 hasConcept C114276007 @default.
• W2153763521 hasConcept C126322002 @default.

• next